Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The effect of pharmacological agents on uterine junctional zone contractions during mock embryo transfer: a randomised double blind study
ISRCTN ISRCTN57835722
ClinicalTrials.gov identifier
Public title The effect of pharmacological agents on uterine junctional zone contractions during mock embryo transfer: a randomised double blind study
Scientific title
Acronym N/A
Serial number at source N0084096582
Study hypothesis To assess if junctional zone contractions can be reduced by pharmacological agents.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised double blind study
Countries of recruitment United Kingdom
Disease/condition/study domain Pregnancy and Childbirth: Embryo transfer
Participants - inclusion criteria Not provided at time of registration
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/04/2000
Anticipated end date 10/12/2003
Status of trial Completed
Patient information material
Target number of participants 80
Interventions The patient's baseline junctional zone contractions will be established following a 5 minute scan. Video tapes taken of both the pre and post mock embryo transfer will be assessed by two researchers who will be unaware of treatment.
20 patients allocated to the nitric oxide group, 20 to the non-steroidal anti-inflammatory group, 20 control and 20 to the COX-2 inhibitor group.
Primary outcome measure(s) 1. Number of contractions per unit time
2. Speed of contractions in cm/min
3. Type of contractions
4. Speed of Echovist
5. Distance traveled by Echovist
Secondary outcome measure(s) Not provided at time of registration
Sources of funding The North and South Bank Research and Development Consortium (UK)
Trial website
Publications
Contact name Dr  Frank  Biervliet
  Address Academic Department of Obstetrics & Gynaecology
Hull & East Yorkshire (NHS) Trust
The Princess Royal Hospital
Salthouse Road
  City/town Hull
  Zip/Postcode HU8 9HE
  Country United Kingdom
  Tel +44 (0)1482 701151
  Email
Sponsor Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
  Address The Department of Health,
Richmond House,
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2004
Last edited 02/11/2011
Date ISRCTN assigned 30/09/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central